These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30179501)

  • 1. Theoretical Simulation of Red Cell Sickling Upon Deoxygenation Based on the Physical Chemistry of Sickle Hemoglobin Fiber Formation.
    Dunkelberger EB; Metaferia B; Cellmer T; Henry ER
    J Phys Chem B; 2018 Dec; 122(49):11579-11590. PubMed ID: 30179501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell disease.
    Henry ER; Cellmer T; Dunkelberger EB; Metaferia B; Hofrichter J; Li Q; Ostrowski D; Ghirlando R; Louis JM; Moutereau S; Galactéros F; Thein SL; Bartolucci P; Eaton WA
    Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15018-15027. PubMed ID: 32527859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of deoxygenation on whole-cell conductance of red blood cells from healthy individuals and patients with sickle cell disease.
    Browning JA; Staines HM; Robinson HC; Powell T; Ellory JC; Gibson JS
    Blood; 2007 Mar; 109(6):2622-9. PubMed ID: 17138828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry.
    Rab MAE; van Oirschot BA; Bos J; Kanne CK; Sheehan VA; van Beers EJ; van Wijk R
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
    Schroeder P; Fulzele K; Forsyth S; Ribadeneira MD; Guichard S; Wilker E; Marshall CG; Drake A; Fessler R; Konstantinidis DG; Seu KG; Kalfa TA
    J Pharmacol Exp Ther; 2022 Mar; 380(3):210-219. PubMed ID: 35031585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
    Rab MAE; van Oirschot BA; Bos J; Merkx TH; van Wesel ACW; Abdulmalik O; Safo MK; Versluijs BA; Houwing ME; Cnossen MH; Riedl J; Schutgens REG; Pasterkamp G; Bartels M; van Beers EJ; van Wijk R
    Am J Hematol; 2019 May; 94(5):575-584. PubMed ID: 30784099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies.
    Lu L; Li Z; Li H; Li X; Vekilov PG; Karniadakis GE
    Sci Adv; 2019 Aug; 5(8):eaax3905. PubMed ID: 31457104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia.
    Strader MB; Liang H; Meng F; Harper J; Ostrowski DA; Henry ER; Shet AS; Eaton WA; Thein SL; Alayash AI
    Bioconjug Chem; 2019 Mar; 30(3):568-571. PubMed ID: 30794381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
    Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
    Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxelotor does not inhibit sickle hemoglobin fiber formation upon complete deoxygenation.
    Worth EH; Fugate MK; Ferrone FA
    Biophys J; 2023 Jul; 122(13):2782-2790. PubMed ID: 37270670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of sickling on ion transport. I. Effect of sickling on potassium transport.
    TOSTESON DC; CARLSEN E; DUNHAM ET
    J Gen Physiol; 1955 Sep; 39(1):31-53. PubMed ID: 13252234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?
    Oder E; Safo MK; Abdulmalik O; Kato GJ
    Br J Haematol; 2016 Oct; 175(1):24-30. PubMed ID: 27605087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells.
    Nakagawa A; Ferrari M; Schleifer G; Cooper MK; Liu C; Yu B; Berra L; Klings ES; Safo RS; Chen Q; Musayev FN; Safo MK; Abdulmalik O; Bloch DB; Zapol WM
    Mol Pharm; 2018 May; 15(5):1954-1963. PubMed ID: 29634905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hemoglobin concentration on deformability of individual sickle cells after deoxygenation.
    Itoh T; Chien S; Usami S
    Blood; 1995 Apr; 85(8):2245-53. PubMed ID: 7718897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse.
    Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL
    J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alizarin interaction with sickle hemoglobin: elucidation of their anti-sickling properties by multi-spectroscopic and molecular modeling techniques.
    Syed MM; Doshi PJ; Kulkarni MV; Dhavale DD; Kadam NS; Kate SL; Doshi JB; Sharma N; Uppuladinne M; Sonavane U; Joshi R; Doshi SJ; Bhattacharya N
    J Biomol Struct Dyn; 2019 Oct; 37(17):4614-4631. PubMed ID: 30558488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between morphologic characteristics of sickle cells and method of deoxygenation.
    Asakura T; Mayberry J
    J Lab Clin Med; 1984 Dec; 104(6):987-94. PubMed ID: 6502005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a small molecule that increases hemoglobin oxygen affinity and reduces SS erythrocyte sickling.
    Nakagawa A; Lui FE; Wassaf D; Yefidoff-Freedman R; Casalena D; Palmer MA; Meadows J; Mozzarelli A; Ronda L; Abdulmalik O; Bloch KD; Safo MK; Zapol WM
    ACS Chem Biol; 2014 Oct; 9(10):2318-25. PubMed ID: 25061917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular insights of inhibition in sickle hemoglobin polymerization upon glutathionylation: hydrogen/deuterium exchange mass spectrometry and molecular dynamics simulation-based approach.
    Das R; Mitra A; Mitra G; Maity D; Bhat V; Pal D; Ross C; Kurpad AV; Mandal AK
    Biochem J; 2018 Jul; 475(13):2153-2166. PubMed ID: 29858275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.